| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell and Tumor Biology |
1 Department of Pharmacology, Nippon Dental University, School of Dentistry at Tokyo, Tokyo, Japan and 2 Laboratory of Biosystems and Cancer, National Cancer Institute, NIH, Bethesda, Maryland
Requests for reprints: J. Carl Barrett, Center for Cancer Research, National Cancer Institute, Building 31, Room 3A11, 31 Center Drive, MSC-2440, Bethesda, MD 20892-2240. Phone: 301-496-4345; Fax: 301-496-0775; E-mail: barrett{at}mail.nih.gov.
Immortal cell lines and tumors maintain their telomeres via the telomerase pathway or via a telomerase-independent pathway, referred to as alternative lengthening of telomeres (ALT). Here, we show the reversible conversion of the human papillomavirus type 16 E6-induced immortal human fibroblasts E6 Cl 6 from telomerase-positive (Tel+) to telomerase-negative (Tel) cells. Tel+ cells converted spontaneously to Tel cells that reverted to Tel+ cells following treatment with trichostatin A (TSA) and/or 5-aza-2'-deoxycytidine (5-AZC), which induced the reversion from complete to partial methylation of the CpG islands of the human telomerase reverse transcriptase (hTERT) promoter in Tel E6 Cl 6 cells. Tel E6 Cl 6 cells lacked the phenotypes characteristic of ALT cell lines such as very long and heterogenous telomeres and ALT-associated promyelocytic leukemia nuclear bodies (APB) but grew for >240 population doublings (PD) after they became telomerase negative. The ratios of histone H3 (H3) lysine (K) 9 methylation to each of H3-K4 methylation, H3-K9 acetylation, and H3-K14 acetylation of the chromatin containing the hTERT promoter in Tel E6 Cl 6 cells and ALT cell lines were greater than those in Tel+ cells and decreased following treatment with TSA and/or 5-AZC, inversely corresponding to telomerase activity. Our findings suggest the possibility that human tumors may be able to reversibly interconvert their telomere maintenance phenotypes by chromatin structure-mediated regulation of hTERT expression.
Key Words: immortal human cells telomerase alternative lengthening of telomeres DNA methylation chromatin structure
This article has been cited by other articles:
![]() |
L. Liu, K. Ishihara, T. Ichimura, N. Fujita, S. Hino, S. Tomita, S. Watanabe, N. Saitoh, T. Ito, and M. Nakao MCAF1/AM Is Involved in Sp1-mediated Maintenance of Cancer-associated Telomerase Activity J. Biol. Chem., February 20, 2009; 284(8): 5165 - 5174. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Liu, X. Fang, Z. Ge, M. Jalink, S. Kyo, M. Bjorkholm, A. Gruber, J. Sjoberg, and D. Xu The Telomerase Reverse Transcriptase (hTERT) Gene Is a Direct Target of the Histone Methyltransferase SMYD3 Cancer Res., March 15, 2007; 67(6): 2626 - 2631. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Renaud, D. Loukinov, Z. Abdullaev, I. Guilleret, F. T. Bosman, V. Lobanenkov, and J. Benhattar Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene Nucleic Acids Res., February 28, 2007; 35(4): 1245 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Brachner, S. Sasgary, C. Pirker, C. Rodgarkia, M. Mikula, W. Mikulits, H. Bergmeister, U. Setinek, M. Wieser, S.-F. Chin, et al. Telomerase- and Alternative Telomere Lengthening-Independent Telomere Stabilization in a Metastasis-Derived Human Non-Small Cell Lung Cancer Cell Line: Effect of Ectopic hTERT. Cancer Res., April 1, 2006; 66(7): 3584 - 3592. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Muntoni and R. R. Reddel The first molecular details of ALT in human tumor cells Hum. Mol. Genet., October 15, 2005; 14(suppl_2): R191 - R196. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Atkinson, S. F. Hoare, R. M. Glasspool, and W. N. Keith Lack of Telomerase Gene Expression in Alternative Lengthening of Telomere Cells Is Associated with Chromatin Remodeling of the hTR and hTERT Gene Promoters Cancer Res., September 1, 2005; 65(17): 7585 - 7590. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |